摘要
目的评价Ahmed青光眼阀(AGV)植入术治疗难治性青光眼的早期和中远期临床疗效,探讨术后早期和中远期并发症的防治。方法对35例(35只眼)难治性青光眼患者施行Ahmed青光眼阀植入术,术后随访3~66个月,对术前术后眼压采用配对比较。结果术前平均眼压为(43.17±11.54)mmHg,术后早期(术后第7~10天)平均眼压为(13.11±5.52)mmHg(P<0.01),成功率为91.43%;中远期平均眼压为(19.03±9.17)mmHg(P<0.01),成功率为80%。术后早期常见的并发症有前房出血12只眼(34.29%)、前房形成迟缓及低眼压9只眼(25.71%)及一过性高眼压5只眼(11.43%)等;中远期常见并发症有盘周纤维包裹6只眼(17.14%),引流管外露1只眼(2.86%),角膜失代偿1只眼(2.86%)。结论尽管Ahmed青光眼阀植入术存在一些不容忽视的并发症,但仍不失为治疗难治性青光眼的一种有效方法。
Objective To evaluate the short-term and medium-long-term clinical efficacy of Ahmed glaucoma valve (AGV) implantation for refractory glaucoma and discuss the prevention and treatment of postoperative complications. Methods Retrospective medical records from 35 patients (35 eyes) with refractory glaucoma who underwent AGV implantation with a minimum of three months of follow-up were reviewed. Results The intraocular pressure(IOP) was reduced from a mean of (43.17±11.54) mm Hg to (13.11±5.52) mm Hg(P0.01) at 7~10 days after operation and (19.03±9.17) mm Hg(P0.01)at 3~66 months after operation. The probability of success was 91.43% and 80% respectively. The best postoperative corrected visual acuity was improved in 10 eyes (28.57%),without improvement in 18 eyes (51.43%) and decreased in 7 eyes (20%). The early major complications included hyphema (34.29%),shallow anterior chamber and transient hypotony (25.71%),transient ocular hypertension (11.34%). The late major complications were encapsulated bleb (17.14%),exposure of tube (2.86%) and corneal decompensation (2.86%). Conclusion Ahmed valve implantation is an effective method in the management of refractory glaucoma in spite of its unnegligible complications.
出处
《临床眼科杂志》
2009年第6期514-517,共4页
Journal of Clinical Ophthalmology